Filipino gout: A review

Arthritis Care and Research

Volumn 66, Issue 3, 2014, Pages 337-343

  Prasad, Pooja ^a   Krishnan, Eswar ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; ORGANIC ANION TRANSPORTER 4; PROTEIN; SLC2A9 PROTEIN; UNCLASSIFIED DRUG; URATE TRANSPORTER; URIC ACID;

COMORBIDITY; ENVIRONMENTAL FACTOR; FILIPINO; GENETIC VARIABILITY; GOUT; HEALTH CARE UTILIZATION; HEALTH DISPARITY; HUMAN; HYPERURICEMIA; KIDNEY FUNCTION; LIFESTYLE; MIGRATION; PACIFIC ISLANDER; PHILIPPINES; PREVALENCE; REVIEW; URIC ACID BLOOD LEVEL;

GOUT; HUMANS; HYPERURICEMIA; PACIFIC ISLANDS; PHILIPPINES;

EID: 84896875506     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22118     Document Type: Review

References (57)

1. Central Intelligence Agency. The World Factbook. 2013. URL: https://www.cia.gov/library/publications/the-world-factbook/geos/rp.html.
2. Healey LA, Skeith MD, Decker JL, Bayani-Sioson PS,. Hyperuricemia in Filipinos: interaction of heredity and environment. Am J Hum Genet 1967; 19: 81-5.
3. Lal BV, Fortune K,. The Pacific Islands: an encyclopedia. China: University of Hawai'i Press; 2000.
4. Paterson J, Percival T, Schluter P, Sundborn G, Abbot M, Carter S, et al. Cohort profile: the Pacific Islands Families (PIF) study. Int J Epidemiol 2008; 37: 273-9.
5. Barnes JS, Bennett CE,. Asian population: 2000. Census 2000 brief. Darby (PA): Diane Publishing; 2010.
6. Barringer HR, Gardner RW, Levin MJ,. Asians and Pacific Islanders in the United States. New York: Russell Sage Foundation; 1993.
7. Krishnan E,. Gout: epidemiology and risk factors. In:, Terkeltaub R, editor. Gout and other crystal arthropathies. 1st ed. Philadelphia: Saunders; 2012. p. 72-84.
8. Krishnan E,. Reduced glomerular function and prevalence of gout: NHANES 2009-10. PLoS One 2012; 7: e50046.
9. Chen EW, Yoo GJ,. Encyclopedia of Asian American issues today: volume 1. Santa Barbara (CA): ABC-CLIO; 2010.
10. Wigley R, Manahan L, Muirden KD, Caragay R, Pinfold B, Couchman KG, et al. Rheumatic disease in a Philippine village. II: a WHO-ILAR-APLAR COPCORD study, phases II and III. Rheumatol Int 1991; 11: 157-61.
11. Dans LF, Tankeh-Torres S, Amante CM, Penserga EG,. The prevalence of rheumatic diseases in a Filipino urban population: a WHO-ILAR COPCORD study. J Rheumatol 1997; 24: 1814-9.
12. Decker JL, Lane JJ,. Gouty arthritis in Filipinos. N Engl J Med 1959; 261: 805-6.
13. Rosenblatt G, Decker JL, Healey LA Jr., Gout in hospitalized Filipinos in Hawaii. Pac Med Surg 1966; 74: 312-3.
14. Fisher HW,. The diseases of Filipino men. Hawaii Med J 1959; 18: 252-4.
15. Manahan LA, Portes JC,. Serum uric acid and gout in a select Filipino population. Philipp J Intern Med 1973; 11: 62-79.
16. Manahan LA,. Rheumatic disease in the Philippines. In: Australian Rheumatism Congress. Proceedings. Sydney; 1964. p. 20-2.
17. Decker JL, Lane JJ Jr, Reynolds WE,. Hyperuricemia in a male Filipino population. Arthritis Rheum 1962; 5: 144-55.
18. Healey LA Jr, Caner JE, Decker JL,. Ethnic variations in serum uric acid. I. Filipino hyperuricemia in a controlled environment. Arthritis Rheum 1966; 9: 288-94.
19. Steuermann N, Farias AH,. Hyperuricemia in Filipinos. Hawaii Med J 1960; 20: 151-3.
20. Bayani-Sioson PS, Healey LA, Decker JL,. Are Filipinos hyperuricemia? Acta Med Philipp 1966; 2: 206-7.
21. Bayani-Sioson PS, Bautista EM,. The blood uric acid level in a Filipino population using colorimetric and enzymatic methods. Acta Med Philipp 1965; 2: 88-9.
22. Bayani-Sioson PS, Skeith M, Healey LS,. On Filipino hyperuricemia. Acta Med Philipp 1966; 3: 126-7.
23. Kelley RR, Sprague C, Sonoda PA, Akina EG,. Serum uric acid levels of Queen's Medical Center employees: a pilot study. Hawaii Med J 1968; 27: 403-4.
24. Reyes GL,. Some observations on blood uric acid in health. Bull VLGH 1965; 6: 29-35.
25. Healey LA, Bayani-Sioson PS,. A defect in the renal excretion of uric acid in Filipinos. Arthritis Rheum 1971; 14: 721-6.
26. Torralba TP, Bayani-Sioson PS,. The Filipino and gout. Semin Arthritis Rheum 1975; 4: 307-20.
27. Kolonel LN, Hankin JH, Nomura AM,. Multiethnic studies of diet, nutrition, and cancer in Hawaii. Princess Takamatsu Symp 1985; 16: 29-40.
28. Novotny R, Vijayadeva V, Grove J, Gittlesohn J, Avila J, Su Y, et al. Dietary intake among native Hawaiian, Filipino, and white children and caregivers in Hawai'i. Hawaii J Med Public Health 2012; 71: 353-8.
29. Johnson-Kozlow M, Matt GE, Rock CL, de la Rosa R, Conway TL, Romero RA,. Assessment of dietary intakes of Filipino-Americans: implications for food frequency questionnaire design. J Nutr Educ Behav 2011; 43: 505-10.
30. Choi HK,. Diet, alcohol, obesity, hyperuricemia, and risk of gout. In:, Terkeltaub R, editor. Gout and other crystal arthropathies. 1st ed. Philadelphia: Saunders; 2012. p. 131-47.
31. Choi HK, Atkinson K, Karlson EW, Curhan G,. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005; 165: 742-8.
32. Campion EW, Glynn RJ, DeLabry LO,. Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study. Am J Med 1987; 82: 421-6.
33. DiPasquale-Davis J, Hopkins SJ,. Health behaviors of an elderly Filipino group. Public Health Nurs 1997; 14: 118-22.
34. Maxwell AE, Crespi CM, Alano RE, Sudan M, Bastani R,. Health risk behaviors among five Asian American subgroups in California: identifying intervention priorities. J Immigr Minor Health 2012; 14: 890-4.
35. Huang B, Appel HB, Nicdao EG, Lee HJ, Ai AL,. Chronic conditions, behavioral health, and use of health services among Asian American men: the first nationally representative sample. Am J Mens Health 2013; 7: 66-76.
36. Williams AE, Vogt TM, Stevens VJ, Albright CA, Nigg CR, Mennan RT, et al. Work, weight, and wellness: the 3W Program. A worksite obesity prevention and intervention trial. Obesity (Silver Spring) 2007; 15 Suppl: 16S-26S.
37. Novotny R, Williams AE, Vinoya AC, Oshiro CE, Vogt TM,. US acculturation, food intake, and obesity among Asian-Pacific hotel workers. J Am Diet Assoc 2009; 109: 1712-8.
38. Krishnan E, Lienesch D, Kwoh CK,. Gout in ambulatory care settings in the United States. J Rheumatol 2008; 35: 498-501.
39. Rhee SO, Lyons TF, Payne BC,. Patient race and physician performances: quality of medical care, hospital admissions and hospital stays. Med Care 1979; 17: 737-47.
40. Juarez DT, Samoa RA, Chung RS, Seto TB,. Disparities in health, obesity and access to care among an insured population of Asian and Pacific Islander Americans in Hawai'i. Hawaii Med J 2010; 69: 42-6.
41. Hollis-Moffatt JE, Xu X, Dalbeth N, Merriman ME, Topless R, Waddell C, et al. Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets. Arthritis Rheum 2009; 60: 3485-92.
42. Reginato AM, Mount DB, Yang I, Choi HK,. The genetics of hyperuricaemia and gout. Nat Rev Rheumatol 2012; 8: 610-21.
43. Choi HK, Zhu Y, Mount DB,. Genetics of gout. Curr Opin Rheumatol 2010; 22: 144-51.
44. George RL, Keenan RT,. Genetics of hyperuricemia and gout: implications for the present and future. Curr Rheumatol Rep 2013; 15: 309.
45. Riches PL,. Genetics of gout. In:, Terkeltaub R, editor. Gout and other crystal arthropathies. 1st ed. Philadelphia: Saunders; 2012. p. 85-93.
46. Zhu Y, Pandya BJ, Choi HK,. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med 2012; 125: 679-87.
47. Buckley HR,. Possible gouty arthritis in Lapita-associated skeletons from Teouma, Efate Island, Central Vanuatu. Curr Anthropol 2007; 48: 741-9.
48. Prior IA, Stanhope JM, Evans JG, Salmond CE,. The Tokelau Island Migrant Study. Int J Epidemiol 1974; 3: 225-32.
49. Wigley RD, Manahan L, Caragay R, Muirden KD, Valkenberg HA, Allander E, et al. Observations on rheumatic disease in Polynesia and the Philippines. J Rheumatol Suppl 1983; 10: 37-40.
50. Rose BS,. Gout in Maoris. Semin Arthritis Rheum 1975; 5: 121-45.
51. Lennane GA, Rose BS, Isdale IC,. Gout in the Maori. Ann Rheum Dis 1960; 19: 120-5.
52. Dalbeth N, Kumar S, Stamp L, Gow P,. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. J Rheumatol 2006; 33: 1646-50.
53. Dalbeth N, Collis J, Gregory K, Clark B, Robinson E, McQueen FM,. Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford) 2007; 46: 1804-7.
54. Brauer GW, Prior IA,. A prospective study of gout in New Zealand Maoris. Ann Rheum Dis 1978; 37: 466-72.
55. Gill T,. Epidemiology and health impact of obesity: an Asia Pacific perspective. Asia Pac J Clin Nutr 2006; 15 Suppl: 3-14.
56. Phipps-Green AJ, Hollis-Moffatt JE, Dalbeth N, Merriman ME, Topless R, Gow PJ, et al. A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets. Hum Mol Genet 2010; 19: 4813-9.
57. Simmonds HA, McBride MB, Hatfield PJ, Graham R, McCaskey J, Jackson M,. Polynesian women are also at risk for hyperuricaemia and gout because of a genetic defect in renal urate handling. Br J Rheumatol 1994; 33: 932-7.